Zimbabwe has declined a significant US healthcare agreement valued at $367m (£272m) spanning five years over the United States' request for confidential biological samples.
The decision was revealed after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "unbalanced".
An official representative has since stated that the US was requesting health data for scientific study and commercial gain while refused to guarantee the benefits from future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for continued talks to find a agreement suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This development follows a comparable case in Kenya, where a court blocked a related deal with the US following legal challenges were filed about the safety of citizens' medical information.
Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to enhance transparency and accountability.
Based on reports, 16 African countries have to date signed similar agreements, constituting over $18.3bn in committed funds.
Specifics of the Declined Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this collaboration could have provided significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," Tremont added.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no corresponding guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could result from that shared data," his statement read.
"Put simply, our country would supply the raw materials for medical research without any assurance that the end products would be accessible to our population if a new health crisis emerge."
National Interest and International Frameworks
Mangwana further pointed out that the American exit from the global health body and its push of bilateral deals were undermining structures already set up through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage potential pandemics.
"This mechanism is designed to guarantee that when a nation provides its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to ongoing discussions with our US partners on how subsequent collaboration might be designed in a manner that respects the independence and dignity of both nations."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but urged that negotiations should continue given that much of the country's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," it said.
This impasse highlights the complex challenges between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.